Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Drug and Alcohol Dependence
|
March 17, 2022
Gender-specific correlates of nonmedical use of prescription medications in a diverse primary care sample
Taylor B Crouch, Caitlin E Martin, Kathryn Polak, et al.
Pain Medicine (Malden, Mass.)
|
October 11, 2025
Relationships Among Childhood Trauma, Central Sensitization, and Opioid-Related Risks in a Community Sample of Adults with Chronic Pain on Opioids
Taylor B Crouch, John A Sturgeon, Maggie Nguyen, et al.
Modern Clinical Medicine Research
|
September 16, 2021
Survey of Physician Perspective towards Management of Pain for Chronic Conditions in the Emergency Department
Daniel Sop, Wally Smith, Abdulkhaliq Alsalman, et al.
Biomed Research International
|
February 7, 2023
Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study
Clark Brown, Modupe Idowu, Richard Drachtman, et al.
American Journal of Hematology
|
June 1, 2010
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
Martin H Steinberg, William F McCarthy, Oswaldo Castro, et al.
American Journal of Hematology
|
March 29, 2014
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease
Marvin E Reid, Amal El Beshlawy, Adlette Inati, et al.
Blood Advances
|
August 26, 2025
Improvements in Health-Related Quality of Life in Patients with Severe Sickle Cell Disease After Exagamglogene Autotemcel
Akshay Sharma, Franco Locatelli, Monica Bhatia, et al.
American Journal of Hematology
|
January 15, 2019
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study
Lakshmanan Krishnamurti, Donna S Neuberg, Keith M Sullivan, et al.
Blood Advances
|
August 27, 2025
Improvements in Health-Related Quality of Life in Patients with Transfusion-Dependent β-Thalassemia After Exagamglogene Autotemcel
Josu de la Fuente, Haydar Frangoul, Peter Lang, et al.
JAMA
|
April 4, 2003
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment
Martin H Steinberg, Franca Barton, Oswaldo Castro, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Drug and Alcohol Dependence
|
March 17, 2022
Gender-specific correlates of nonmedical use of prescription medications in a diverse primary care sample
Taylor B Crouch, Caitlin E Martin, Kathryn Polak, et al.
Pain Medicine (Malden, Mass.)
|
October 11, 2025
Relationships Among Childhood Trauma, Central Sensitization, and Opioid-Related Risks in a Community Sample of Adults with Chronic Pain on Opioids
Taylor B Crouch, John A Sturgeon, Maggie Nguyen, et al.
Modern Clinical Medicine Research
|
September 16, 2021
Survey of Physician Perspective towards Management of Pain for Chronic Conditions in the Emergency Department
Daniel Sop, Wally Smith, Abdulkhaliq Alsalman, et al.
Biomed Research International
|
February 7, 2023
Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study
Clark Brown, Modupe Idowu, Richard Drachtman, et al.
American Journal of Hematology
|
June 1, 2010
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
Martin H Steinberg, William F McCarthy, Oswaldo Castro, et al.
American Journal of Hematology
|
March 29, 2014
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease
Marvin E Reid, Amal El Beshlawy, Adlette Inati, et al.
Blood Advances
|
August 26, 2025
Improvements in Health-Related Quality of Life in Patients with Severe Sickle Cell Disease After Exagamglogene Autotemcel
Akshay Sharma, Franco Locatelli, Monica Bhatia, et al.
American Journal of Hematology
|
January 15, 2019
Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study
Lakshmanan Krishnamurti, Donna S Neuberg, Keith M Sullivan, et al.
Blood Advances
|
August 27, 2025
Improvements in Health-Related Quality of Life in Patients with Transfusion-Dependent β-Thalassemia After Exagamglogene Autotemcel
Josu de la Fuente, Haydar Frangoul, Peter Lang, et al.
JAMA
|
April 4, 2003
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment
Martin H Steinberg, Franca Barton, Oswaldo Castro, et al.
Page
of 4